Study S001306

Research of Intensive Metabolic Intervention Before Pregnancy in Polycystic Ovary Syndrome

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03383068
Acronym: PCOS
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 160
Start: 2018-01-01
Primary completion: 2018-12-31
Lead sponsor: RenJi Hospital
Conditions: PCOS; Impaired Glucose Tolerance
Interventions: DRUG:Acarbose 100 MG; DRUG:Exenatide; DRUG:Orlistat; DRUG:Metformin
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Improvement of pregnant rate after intensive metabolic intervention [up to 24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.